[Global Kinetics in PR Newswire] Global Kinetics Corporation and Parkinson’s Foundation announce first patient enrolled in APPRISE clinical study for optimization of Parkinson’s treatment

Global Kinetics Corporation (GKC), a leader in digital health technology for people with Parkinson’s disease, and the Parkinson’s Foundation today announced that the first of over 400 patients has been enrolled in the GKC APPRISE clinical study.

The multi-center, randomized, controlled study will assess the use of the Personal KinetiGraph™ (PKG™) system for identifying patients who require a change to their clinical management plan and the platform’s ability to help improve patient outcomes.

Read more on PR Newswire here.